Navigation Links
Chimerix Raises $16.1 Million in Series E Financing
Date:8/11/2009

RESEARCH TRIANGLE PARK, N.C., Aug. 11 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, today announced the completion of a $16.1 million Series E financing. Leading life science venture capital investors Canaan Partners, Alta Partners, Sanderling Ventures and Asset Management Company participated in this insider round.

Proceeds from the financing will primarily be used to expand Chimerix's clinical development program for its lead drug candidate, CMX001. CMX001 has shown activity in early clinical studies as a broad-spectrum antiviral drug, and is currently being evaluated for the treatment of cytomegalovirus (CMV) and BK virus in Phase II clinical trials. CMX001 is also being developed as a biodefense agent for the treatment of smallpox and complications associated with smallpox vaccination. In addition, Chimerix expects to advance CMX157, an anti-HIV drug, into Phase I clinical development and to continue work on a library of compounds that have shown extremely potent activity against a range of viral diseases including hepatitis C.

"Chimerix's robust pharmaceutical product pipeline and world-class expertise in the area of antiviral medicines offer truly novel and promising approaches for the treatment of a number of challenging viral and inflammatory diseases," said Seth Rudnick, M.D., of Canaan Partners and Co-Chairman of the company's Board of Directors. "We believe that this financing will enable the Chimerix team to continue doing what they do best - identify, optimize and develop important new antiviral medicines that address significant therapeutic markets and may prove valuable in our nation's biodefense strategy."

"We are pleased by the consistent support Chimerix has received from such a premier group of experienced life science investors," said George Painter, Ph.D., Chimerix's President and Chief Execut
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ex-House Aging Committee Chief of Staff Bob Weiner Warns of Insurance Control Over Health Bill Outcome, Praises House Version, Disappointed by Senate; Weiner and Policy Analyst Jordan Osserman Offer Bills Prognosis
2. High cholesterol in midlife raises risk of late-life dementia, Kaiser Permanente study finds
3. High Cholesterol in Midlife Raises Risk of Late-Life Dementia, Kaiser Permanente Study Finds
4. HMS Holdings Corp. Announces Q2 2009 Results and Raises 2009 Guidance
5. Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
6. Be a Hero For Babies Day Raises $2.6 Million for March of Dimes
7. Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance
8. Universal Health Services, Inc. Reports Significant Increases In 2009 Second Quarter and Six-Month Earnings, Raises Full Year Guidance
9. aTyr Pharma Raises an Additional $12 Million
10. Applied Physiology Raises $5 Million for Navigator™ Market Launch
11. Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... York (PRWEB) March 03, 2015 ... used to market the atypical antipsychotic medication continue ... According to court documents, the South Carolina Supreme ... that Johnson & Johnson’s Janssen Pharmaceuticals unit had ... risks. However, while the Court’s February 25th decision ...
(Date:3/3/2015)... Longtime parent visionary and inspiring new father, Lucas ... for a candid interview on the surrogacy process in ... revelation of his magical surrogacy journey — detailing the ... the birth of his precious twin girls. , ... Founder of CARE stated, “We are committed to maintaining ...
(Date:3/3/2015)... Man, Woman & Student of the Year ... and ensure access to treatments for blood cancer patients, ... their families. Through this annual national ten-week campaign, individuals ... a world without blood cancers. The national titles will ... to be announced this summer. To date, these dedicated ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 The ... the public’s expectation of excellence in care and safe ... the position of the RNS that biologic infusions are ... under the direct supervision of a registered nurse (RN), ... reactions, including anaphylaxis can occur in patients receiving these ...
(Date:3/3/2015)... The human augmentation market is mainly driven ... wearable augmentation sector is predicted to outpace the in-built ... years. , The eye-wear sector dominates the North ... of new products launches in the region. Furthermore, strong ... as well as the rising demand for advantageous products ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2
... The American Association for Dental Research (AADR) has ... AADR William B. Clark Fellowship in Clinical Research. This ... Meeting & Exhibition in Washington, DC, March 3, 2010. ... Department of Periodontics, University of Texas, Health Science at ...
... ... children and we are working with our members to develop new tools to keep the ... ... International Consumer Product Health & Safety Organization’s (ICPHSO) CPSC Day in Washington, D.C. on February ...
... radiation may not be necessary for early malignancy, study ... alone offers a reasonable overall level of survival for ... new study suggests. , Traditional treatment regimens for limited ... study, researchers analyzed U.S. National Cancer Institute data on ...
... , ... ... ... ...
... ... vitamin and supplement retailer recently launched a robust health encyclopedia offering health news and ... knowledge and more. , ... Shelby Township, Mich. (PRWEB) February 19, 2010 -- eVitamins™, a leading online retailer ...
... Ecological, physiological similarities provide basis for insights, expert says, ... that dolphins suffer from diseases similar to those found ... on the effects that contaminated water and seafood have ... and their diet includes much of the same seafood ...
Cached Medicine News:Health News:JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts 2Health News:JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts 3Health News:JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts 4Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 2Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 3Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 4Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 5Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 6Health News:eVitamins Launches New Health Encyclopedia 2Health News:Dolphins May Warn of Health Risks in Humans 2
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
(Date:3/3/2015)... , March 3, 2015  AT&T 1 ... today announced that  AT&T  is the connectivity provider for ... was designed to help provide peace of mind to ... the freedom to live active lives with the confidence ... need it. The AT&T network 2 helps power ...
(Date:3/3/2015)... 3, 2015  Cyberonics, Inc. (NASDAQ: CYBX ... treatment and management of epilepsy, today announced it will ... March 11, 2015, in Miami . ... Chief Executive Officer, will speak at 1:05 PM Eastern ... chat format, and no formal materials will be presented.  ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4
... Data presented at AACR 2008, SAN DIEGO, ... owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq,and ... demonstrating that,the Company,s experimental drug candidate, brostallicin, killed ... status. The study, conducted,by Cristina Geroni, Ph.D., et ...
... Inc.,(Nasdaq: MITI ), a biopharmaceutical company developing ... autoimmune diseases, today,presented at the Annual Meeting of ... Diego, CA, preclinical data of two new human ... of acute myelogenous,leukaemia (AML) and melanoma (1). BiTE ...
Cached Medicine Technology:Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling 2Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 2Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 4Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 5
... Latex Foley Catheter, Smooth, non-stick silicone ... but flexible, latex-based construction with large ... round tip with two opposing eyes ... two staggered eyes and a 30cc ...
... 3-way design permits continuous irrigation ... in the Foley Catheter. 3-Way ... construction, as well as LUBRICATH ... variety of models including Suggs, ...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: